Modular Medical Inc(MODD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 21 at 4:05 PM ET (Korea 10/22 05:05)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -10.11 | Insider Own | 7.3% | Shs Outstand | 9.5M | Perf Week | 1.03% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 8.8M | Perf Month | -11.26% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 24.1% | Short Float | 4.42% | Perf Quarter | -35.2% |
| Income | -0.03B | P/S | - | EPS this Y | - | Inst Trans | 4.6% | Short Ratio | 1.37 | Perf Half Y | -60% |
| Sales | 0.00B | P/B | 1.02 | EPS next 5Y | - | ROA | -212.13% | Short Interest | 0.39M | Perf YTD | -81.96% |
| Book/sh | 1.93 | P/C | 4.77 | EPS past 3/5Y | 31.39% 19.08% | ROE | -247.94% | 52W High | -89.45% ($18.67) | Perf Year | -88.99% |
| Cash/sh | 0.41 | P/FCF | - | Sales past 3/5Y | - | ROIC | -260.37% | 52W Low | 14.53% ($1.72) | Perf 3Y | -93.39% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 33.94% | Gross Margin | - | Volatility(W/M) | 23.17% 14.95% | Perf 5Y | -99.25% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.35 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.25 | EPS Q/Q | 67.88% | Profit Margin | - | RSI (14) | 40.73 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.25 | Sales Q/Q | - | SMA20 | -11.76% ($2.23) | Beta | 0.3 | Target Price | $240 |
| Payout | - | Debt/Eq | 0.03 | Earnings | - | SMA50 | -25.21% ($2.63) | Rel Volume | 0.32 | Prev Close | $1.95 |
| Employees | 51 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -65.25% ($5.67) | Avg Volume(3M) | 0.28M | Price | $1.97 |
| IPO | 2018/12/13 | Option/Short | No/Yes | Trades | 343 | Volume | 90,680 | Change | 1.03% |
A micro medical device company developing a simplified patch-style insulin pump for Type 1 diabetes patients. Leveraging its FDA-approved MODD1 and next-generation tubeless patch pump Pivot, the company is in the early commercialization phase, targeting a simplified, lower-cost segment of a market dominated by large players such as Medtronic and Insulet.
Over the past 1 year, on the lower side
89% below its 1-year high.
Traded less than usual. That is 32% of its average volume.
MODD has a sound balance sheet but weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.3%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 24.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #110 of 142 in the industry
Based on market cap of $19M.
NSPR#109 InspireMD Inc $21M PER - MODD#110 Modular Medical Inc $19M PER - 
PAVM#111 PAVmed Inc $18M PER - 
HSCS#112 HeartSciences Inc $17M PER - 
CTSO#113 Cytosorbents Corp $17M PER - 
FAQ
What kind of company is MODD?
MODD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of MODD?
The market cap of MODD is approximately $19M, ranking 5,238 within its sector.
What is the 52-week high and low for MODD?
MODD has recorded a 52-week high of $18.67 and a low of $1.72.
